Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -80.00%25K | 15.74%125K | 19.10%108K | 32.17%90.68K | 16.17%68.61K | -47.50%59.06K | 112.5K | |||
| Operating revenue | -80.00%25K | 15.74%125K | 19.10%108K | 32.17%90.68K | 16.17%68.61K | -47.50%59.06K | --112.5K | ---- | ---- | ---- |
| Cost of revenue | 52.07%428.9K | 45.00%282.04K | 194.51K | |||||||
| Gross profit | -61.58%-360.29K | -171.88%-222.98K | -82.02K | |||||||
| Operating expense | -20.64%152.34M | 27.86%191.97M | 55.37%150.13M | 145.99%96.63M | 133.51%39.28M | -35.61%16.82M | 19.49%26.13M | 189.69%21.87M | 30.33%7.55M | -14.86%5.79M |
| Selling and administrative expenses | 60.86%20.54M | -0.09%12.77M | -6.01%12.78M | 14.45%13.59M | 237.51%11.88M | 15.79%3.52M | 12.58%3.04M | -16.93%2.7M | 13.51%3.25M | 21.25%2.86M |
| -General and administrative expense | 60.86%20.54M | -0.09%12.77M | -6.01%12.78M | 14.45%13.59M | 237.51%11.88M | 15.79%3.52M | 12.58%3.04M | -16.93%2.7M | 13.51%3.25M | 21.25%2.86M |
| Research and development costs | -28.07%126.83M | 36.87%176.33M | 58.18%128.83M | 214.56%81.45M | 114.62%25.89M | -46.19%12.06M | 22.61%22.42M | 391.80%18.29M | 39.02%3.72M | -37.57%2.67M |
| Depreciation amortization depletion | -11.65%91K | 1.98%103K | 28.86%101K | -26.52%78.38K | 10.50%106.67K | 308.93%96.54K | 12.15%23.61K | 2.92%21.05K | -11.06%20.45K | -22.26%22.99K |
| -Depreciation and amortization | -11.65%91K | 1.98%103K | 28.86%101K | -26.52%78.38K | 10.50%106.67K | 308.93%96.54K | 12.15%23.61K | 2.92%21.05K | -11.06%20.45K | -22.26%22.99K |
| Other taxes | 118.18%408K | 41.67%187K | 44.10%132K | 388.14%91.6K | -86.08%18.77K | 116.66%134.85K | --62.24K | ---- | ---- | ---- |
| Other operating expenses | 72.95%4.47M | -68.84%2.58M | 484.82%8.29M | 2.31%1.42M | 37.59%1.39M | 73.06%1.01M | -32.35%582.13K | 53.77%860.45K | 142.35%559.58K | 82.00%230.9K |
| Operating profit | 20.61%-152.31M | -27.87%-191.84M | -55.41%-150.03M | -143.52%-96.54M | -132.57%-39.64M | 34.96%-17.05M | -19.86%-26.21M | -189.69%-21.87M | -30.33%-7.55M | 14.86%-5.79M |
| Net non-operating interest income (expenses) | -52.32%-40.93M | -162.51%-26.87M | -4,446.66%-10.24M | -36.70%235.47K | -22.57%372K | -11.20%480.45K | -26.46%541.03K | 91.41%735.7K | 18.05%384.35K | 0.31%325.57K |
| Non-operating interest income | 62.95%5.53M | 5.21%3.4M | 1,270.46%3.23M | -36.70%235.47K | -22.57%372K | -11.20%480.45K | -26.46%541.03K | 91.41%735.7K | 18.05%384.35K | 0.31%325.57K |
| Non-operating interest expense | 53.51%46.46M | 124.80%30.26M | --13.46M | --0 | --0 | ---- | ---- | ---- | ---- | ---- |
| Other net income (expenses) | 314.72%23.5M | -192.64%-10.94M | 519.77%11.81M | 74.45%-2.81M | -4,021.29%-11.01M | -210.51%-267.23K | 313.50%241.81K | -284.24%-113.26K | 94.95%-29.48K | -334.61%-583.46K |
| Gain on sale of security | 337.83%26.95M | -2,217.18%-11.33M | 82.62%-489K | 74.45%-2.81M | -4,040.01%-11.01M | -210.00%-265.99K | --241.81K | ---- | ---- | ---- |
| Special income (charges) | ---3.45M | --0 | --0 | 88.21%-169 | -15.37%-1.43K | ---1.24K | --0 | -275.46%-115.29K | 94.79%-30.71K | -3,886.91%-589.68K |
| -Less:Restructuring and mergern&acquisition | --3.45M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --668.97K |
| -Gain on sale of property,plant,equipment | ---- | --0 | --0 | 88.21%-169 | -15.37%-1.43K | ---1.24K | --0 | -275.46%-115.29K | -138.73%-30.71K | 409.18%79.29K |
| Other non-operating income (expenses) | ---- | -96.85%387K | --12.3M | ---- | ---- | ---- | ---- | 65.15%2.03K | -80.24%1.23K | -87.03%6.23K |
| Income before tax | 26.09%-169.74M | -54.70%-229.65M | -49.77%-148.45M | -97.12%-99.12M | -198.74%-50.28M | 33.80%-16.83M | -19.69%-25.43M | -195.33%-21.24M | -18.90%-7.19M | 2.88%-6.05M |
| Income tax | 26.19%-6.95M | -58.83%-9.41M | 5.93%-5.93M | -27.55%-6.3M | 13.49%-4.94M | 45.50%-5.71M | -18.65%-10.47M | -262.63%-8.83M | -107.74%-2.43M | 43.83%-1.17M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 26.09%-162.79M | -54.53%-220.24M | -53.55%-142.52M | -104.69%-92.82M | -307.66%-45.34M | 25.61%-11.12M | -20.42%-14.95M | -160.90%-12.42M | 2.44%-4.76M | -17.75%-4.88M |
| Net income continuous operations | 26.09%-162.79M | -54.53%-220.24M | -53.55%-142.52M | -104.69%-92.82M | -307.66%-45.34M | 25.61%-11.12M | -20.42%-14.95M | -160.90%-12.42M | 2.44%-4.76M | -17.75%-4.88M |
| Noncontrolling interests | 73.33%-18.19K | |||||||||
| Net income attributable to the company | 26.09%-162.79M | -54.53%-220.24M | -53.55%-142.52M | -104.69%-92.82M | -307.66%-45.34M | 25.61%-11.12M | -20.42%-14.95M | -160.90%-12.42M | 2.07%-4.76M | -19.27%-4.86M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 26.09%-162.79M | -54.53%-220.24M | -53.55%-142.52M | -104.69%-92.82M | -307.66%-45.34M | 25.61%-11.12M | -20.42%-14.95M | -160.90%-12.42M | 2.07%-4.76M | -19.27%-4.86M |
| Diluted earnings per share | ||||||||||
| Basic earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- |